ARCHIVES

FDA Hears More Criticism On Cancer Drug Endpoints; Joint Conferences On Criteria Recommended

This article is from The Cancer Letter archive.

Vol. 15 No. 30 | July 28, 1989

Download PDF Visit The Full Archive

Related Articles

Funding Opportunities: NCI extends Deadline for Three RFAs

July 9, 1999

Roswell Park, Karmanos Read The Cancer Letter Interactive.

December 1, 2000

Cancer Letter Closes Out 1983, 10th Year

December 16, 1983

National Coalition for Cancer Research Formed To Support Reauthorization, l Research Budgets

April 19, 1985

Breast Cancer Incidence Reduced 45% In Tamoxifen Arm Of BCPT; Trial Unblinded

April 10, 1998

Also von Eschenbach Role in Industry Program Raises New Concerns of Conflict of Interest.

November 22, 2006